Title : COMPARison of pre-hospital CRUSHed vs. uncrushed Prasugrel tablets in patients with STEMI undergoing primary percutaneous coronary interventions: Rationale and design of the COMPARE CRUSH trial.

Pub. Date : 2020 Jun

PMID : 32272255






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Evidence suggests that administration of crushed tablets of the P2Y12 inhibitor prasugrel improves drug absorption and achieves earlier antiplatelet effects in STEMI patients undergoing primary percutaneous coronary intervention (PCI). Prasugrel Hydrochloride purinergic receptor P2Y12 Homo sapiens